FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1464641000168101: mepolizumab 100 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use)

Status: current, Defined. Date: 31-May 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4389491000168110 mepolizumab 100 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4389501000168115 mepolizumab 100 mg/mL injection, syringe en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
mepolizumab 100 mg/mL injection, syringe Is a medicinal product unit of use true Inferred relationship Some
mepolizumab 100 mg/mL injection, syringe Is a mepolizumab true Inferred relationship Some
mepolizumab 100 mg/mL injection, syringe has manufactured dose form injection true Inferred relationship Some
mepolizumab 100 mg/mL injection, syringe has unit of use syringe true Inferred relationship Some 2097812302
mepolizumab 100 mg/mL injection, syringe has intended active ingredient mepolizumab true Inferred relationship Some 822361676
mepolizumab 100 mg/mL injection, syringe has Australian BoSS mepolizumab true Inferred relationship Some 822361676
Inbound Relationships Type Active Source Characteristic Refinability Group
Nucala 100 mg/mL injection, 1 mL syringe Is a True mepolizumab 100 mg/mL injection, syringe Inferred relationship Some
mepolizumab 100 mg/mL injection, 1 mL syringe has MPUU True mepolizumab 100 mg/mL injection, syringe Inferred relationship Some 305505236

Reference Sets

Medicinal product unit of use reference set

Back to Start